Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance Assay

By Mehta R.S.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 225-237

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer

By Eltabbakh G.H.   Piver M.S.   Hempling R.E.   Recio F.O.   Lele S.B.   Marchetti D.L.   Baker T.R.   Blumenson L.E.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Drug resistance in chemotherapy for breast cancer

By Saeki Toshiaki   Tsuruo Takashi   Sato Wakao   Nishikawsa Kiyoshiro  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 84-89

Springer Publishing Company

Access to resources Recommend Favorite

Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study

By Cronin-Fenton Deirdre P.   Hellberg Ylva   Lauridsen Kristina L.   Ahern Thomas P.   Garne Jens Peter   Rosenberg Carol   Silliman Rebecca A.   Sørensen Henrik Toft   Lash Timothy L.   Hamilton-Dutoit Stephen  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 254-261

Informa Healthcare

Access to resources Recommend Favorite

Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens

By Manni A.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 2, 2001-05 ,pp. : 147-156

Springer Publishing Company

Access to resources Recommend Favorite